DRD2 and gastroesophageal reflux disease: Current pharmacogenetic research suggests an association between the DRD2 gene and the response to smoking cessation medications, as well as smoking behavior itself [35], and we also look forward to developing relevant medications for the prevention or treatment of GERD.